Category: Diagnostic Technologies

Diagnostic Technologies

Why Spatial Omics Is Transitioning From ‘Maps’ to ‘Mechanisms’

High-resolution maps showed us where cells live; the next phase of spatial omics is about extracting those cells and uncovering the molecular conversations that shape outcomes.

Diagnostic Technologies

FDA Grants Breakthrough Device Designation for Hemoglobin Variant Test

The test uses miniaturized electrophoresis technology designed to enable decentralized access to quantitative hemoglobin data.

Diagnostic Technologies

What Clinical Lab Leaders Predict for 2026

AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.

Anatomic Pathology

Tempus Launches AI-Powered Digital Pathology Suite for Biomarker Prediction

Tempus has introduced Paige Predict, an AI-powered pathology suite that analyzes H&E slides to predict 123 biomarkers across 16 cancer types when tissue samples are insufficient.

Digital Pathology

Fujifilm Partners with Voicebrook to Add Voice Reporting to Digital Pathology Platform

The integration connects Synapse Pathology with VoiceOver PRO to enable hands-free report generation and CAP-compliant structured data capture.

Clinical Chemistry

Ozelle Unveils AI-Powered Complete Blood Morphology Solution

The all-in-one diagnostic platform combines hematology, biochemistry, and immunoassay testing in a single run.

Flow Cytometry

Flow Cytometry Blood Test for Myeloma MRD Detection Launches

The test offers sensitivity comparable to next-generation sequencing methods while using noninvasive blood specimens instead of bone marrow aspirates.

Hematology & Serology

Simplifying Coagulation Testing for Low-Volume Labs with the Sysmex CA-600 Series

The compact, fully automated hemostasis analyzers are designed for routine testing environments and as a reliable backup instrument in larger labs.

Immunoassay

DPYD Genotyping Assay Receives FDA Breakthrough Device Designation

The qPCR-based test detects variants that increase risk of severe fluoropyrimidine chemotherapy toxicity.

Mass Spectrometry

Labcorp to Implement Roche’s Automated Mass Spectrometry Platform

Labcorp will deploy Roche’s cobas Mass Spec platform in its US labs, marking the first commercial rollout of this fully automated mass spectrometry system to streamline complex diagnostic testing workflows.

Microbiology

Primerdesign Launches Magnetic Bead Extraction Kit for DNA and RNA

The exsig Mag RapidBead Pro kit features a four-step workflow that reduces extraction time to under 20 minutes.

Molecular Diagnostics

Ambry Genetics Reaches 1 Million RNA-Enhanced Genetic Tests

Ambry Genetics has completed its one millionth DNA/RNA genetic test, highlighting increased adoption of RNA-enhanced diagnostics for hereditary cancer and rare diseases, according to the company.

Point-of-Care

Roche Receives FDA Clearance for Point-of-Care Bordetella Test

The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.

Urinalysis & Toxicology

ADLM Updates Emergency Department Drug Testing Guidance

New recommendations address evolving drug landscape and advancing testing technologies since original 2003 guidance.